You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VNDA Buy Disclosure
Duncan Charles Cliff · SEC Form 4 · Filed Nov 5, 2026
Buy
Calculated transaction value
$2.85K
Duncan Charles Cliff Director
VNDA
Transaction date
Nov 3, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 2 days later
VNDA daily price context
Close on/before transaction
$3.75
Nov 3, 2026
First close after public filing
$3.82
Nov 6, 2026
Return after filing · so far
+3.4%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 750 shares @ $3.8
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-449902
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$38.09K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | Buy | Nov 5, 2026 | $22.08K |
| Vanda Pharmaceuticals Inc. VNDA | Buy | Nov 4, 2026 | $13.17K |
| Vanda Pharmaceuticals Inc. VNDA Current | Buy | Nov 3, 2026 | $2.85K |